These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9883844)

  • 21. Factors influencing T-cell turnover in HIV-1-seropositive patients.
    McCune JM; Hanley MB; Cesar D; Halvorsen R; Hoh R; Schmidt D; Wieder E; Deeks S; Siler S; Neese R; Hellerstein M
    J Clin Invest; 2000 Mar; 105(5):R1-8. PubMed ID: 10712441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.
    Mohri H; Perelson AS; Tung K; Ribeiro RM; Ramratnam B; Markowitz M; Kost R; Hurley A; Weinberger L; Cesar D; Hellerstein MK; Ho DD
    J Exp Med; 2001 Nov; 194(9):1277-87. PubMed ID: 11696593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender difference in CD4+ cell counts persist after HIV-1 infection. SEROCO Study Group.
    Delmas MC; Jadand C; De Vincenzi I; Deveau C; Persoz A; Sobel A; Kazatchkine M; Brunet JB; Meyer L
    AIDS; 1997 Jul; 11(8):1071-3. PubMed ID: 9223753
    [No Abstract]   [Full Text] [Related]  

  • 24. Unraveling the strands of HIV's web.
    Pantaleo G
    Nat Med; 1999 Jan; 5(1):27-8. PubMed ID: 9883835
    [No Abstract]   [Full Text] [Related]  

  • 25. Further clinical studies of curdlan sulfate (CRDS)--an anti-HIV agent.
    Gordon M; Guralnik M; Kaneko Y; Mimura T; Goodgame J; Lang W
    J Med; 1995; 26(3-4):97-131. PubMed ID: 8558101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.
    Sachsenberg N; Perelson AS; Yerly S; Schockmel GA; Leduc D; Hirschel B; Perrin L
    J Exp Med; 1998 Apr; 187(8):1295-303. PubMed ID: 9547340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary HIV infection. Clinical and serologic characteristics].
    Sepúlveda C; Thompson L; Castrillón MA; Hurtado C
    Rev Med Chil; 1995 Jan; 123(1):74-80. PubMed ID: 7569449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients.
    Mwaba P; Cassol S; Pilon R; Chintu C; Janes M; Nunn A; Zumla A
    Lancet; 2003 Nov; 362(9394):1459-60. PubMed ID: 14602443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. De novo T-cell generation in patients at different ages and stages of HIV-1 disease.
    Nobile M; Correa R; Borghans JA; D'Agostino C; Schneider P; De Boer RJ; Pantaleo G;
    Blood; 2004 Jul; 104(2):470-7. PubMed ID: 15059846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Life span of circulating membrane CD4 inserted into the plasma membranes of autologous red blood cells of HIV-infected subjects.
    Hollinger FB; Mouneimne Y; Lahart C; Tosi PF; Dimitrov D; Nicolau C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):126-32. PubMed ID: 7749788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Label free detection of CD4+ and CD8+ T cells using the optofluidic ring resonator.
    Gohring JT; Fan X
    Sensors (Basel); 2010; 10(6):5798-808. PubMed ID: 22219687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The α-test: rapid cell-free CD4 enumeration using whole saliva.
    Bristow CL; Babayeva MA; Modarresi R; McArthur CP; Kumar S; Awasom C; Ayuk L; Njinda A; Achu P; Winston R
    J Vis Exp; 2012 May; (63):e3999. PubMed ID: 22644001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+ T lymphocyte count in healthy HIV seronegative adults of north India.
    Jindal N; Arora U
    Indian J Med Microbiol; 2010; 28(1):79-80. PubMed ID: 20061776
    [No Abstract]   [Full Text] [Related]  

  • 34. Ozone-treated blood in the treatment of HIV infection.
    Hooker MH; Gazzard BG
    AIDS; 1992 Jan; 6(1):131. PubMed ID: 1347451
    [No Abstract]   [Full Text] [Related]  

  • 35. Telomeres and HIV disease.
    Effros RB
    Microbes Infect; 2000 Jan; 2(1):69-76. PubMed ID: 10717543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summary of the eighth Immune Restoration Think Tank.
    Proj Inf Perspect; 2000 Mar; (29):18-9. PubMed ID: 12772668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factoring in CD4 T cells during treatment of HIV.
    Coquet JM
    Immunol Cell Biol; 2017 Aug; 95(7):571-572. PubMed ID: 28508894
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of Therapeutic Plasma Exchange in Treatment of Tumefactive Multiple Sclerosis-Associated Low CD4 and CD8 Levels.
    Lew K; Mewada N; Ramanujam S; Hassanzadeh B; Donahue JE; Peddareddygari LR; Moser R; Kososky C; Grewal RP
    Case Rep Neurol; 2016; 8(2):179-184. PubMed ID: 27721782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dominant CD4
    Sponaugle A; Weideman AMK; Ranek J; Atassi G; Kuruc J; Adimora AA; Archin NM; Gay C; Kuritzkes DR; Margolis DM; Vincent BG; Stanley N; Hudgens MG; Eron JJ; Goonetilleke N
    Cell Rep Med; 2023 Nov; 4(11):101268. PubMed ID: 37949070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Significance of the Post-Treatment Neutrophil-to-Lymphocyte Ratio in Pharyngeal Cancers Treated with Concurrent Chemoradiotherapy.
    Yun JM; Chung MK; Baek CH; Son YI; Ahn MJ; Oh D; Kim KW; So YK
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.